Over-representation of a germline variant in the gene encoding RET co-receptor GFRα-1 but not GFRα-2 or GFRα-3 in cases with sporadic medullary thyroid carcinoma
Authors:
- 19 April 2001
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 20 (17) , 2161-2170
Abstract
In contrast to the hereditary form of medullary thyroid carcinoma (MTC), little is known about the etiology of sporadic MTC. Somatic gain-of-function mutations in the RET proto-oncogene, encoding a receptor tyrosine kinase, are found in an average of 40% of sporadic MTC. We analysed 31 sporadic MTC for somatic and germline variants in GFRA1, GFRA2 and GFRA3 which encode the co-receptors of RET. Although there were no somatic mutations in any of the three genes, a sequence variant (−193C>G) in the 5′-UTR of GFRA1 was found in 15% of cases. Three patients were heterozygous (het); another three patients homozygous (hom) for the G variant. The G allele was not observed in 31 race-matched normal controls. Hence, the relative frequency of this variant in sporadic MTC cases and controls differed significantly (PG) in the germline of sporadic MTC cases. Our data suggest that the mechanism is related to over-expression of GFRα-1 and differential subcellular compartmentalization but the precise mechanism as to how it acts as a low penetrance susceptibility allele for the development of sporadic MTC remains to be elucidated.Keywords
This publication has 32 references indexed in Scilit:
- The GDNF family ligands and receptors — implications for neural developmentCurrent Opinion in Neurobiology, 2000
- GDNF Family Neurotrophic Factor Signaling: Four Masters, One Servant?Molecular and Cellular Neuroscience, 1999
- Artemin, a Novel Member of the GDNF Ligand Family, Supports Peripheral and Central Neurons and Signals through the GFRα3–RET Receptor ComplexNeuron, 1998
- GFRα-4 and the tyrosine kinase Ret form a functional receptor complex for persephinCurrent Biology, 1998
- HumanGFRA1: Cloning, Mapping, Genomic Structure, and Evaluation as a Candidate Gene for Hirschsprung Disease SusceptibilityGenomics, 1998
- Mutations of theRET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and Hirschsprung diseaseHuman Mutation, 1997
- GDNF signalling through the Ret receptor tyrosine kinaseNature, 1996
- Single missense mutation in the tyrosine kinasecatalytic domain of the RET protooncogene is associated with multiple endocrineneoplasia type 2B.Proceedings of the National Academy of Sciences, 1994
- Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumoursHuman Molecular Genetics, 1994
- Mutations in the RET proto-oncogene are associated with MEN 2A and FMTCHuman Molecular Genetics, 1993